EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients

Chinmay Bera iD, Nashla Hamdan-Perez, Keyur Patel

Journal of Clinical Medicine · 12.02.2024 · 13 (4) · 1046

DOI: 10.3390/jcm13041046 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.02.2024. Verfasst von Chinmay Bera und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, University Health Network Toronto, Toronto General Hospital, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this review is to provide updated information on the clinical use of non-invasive serum and imaging-based tests for fibrosis assessment in chronic hepatitis B (CHB) virus infection. In recent years, non-invasive tests (NIT) have been increasingly used to determine eligibility for treatment. Liver biopsy is still considered the gold standard for assessing inflammatory activity and fibrosis staging, but it is an invasive procedure with inherent limitations. Simple serum markers such as APRI and FIB-4 are limited by indeterminate results but remain useful initial tests for fibrosis severity if imaging elastography is not available. Point-of-care US-based elastography techniques, such as vibration-controlled transient elastography or 2D shear wave elastography, are increasingly available and have better accuracy than simple serum tests for advanced fibrosis or cirrhosis, although stiffness cut-offs are variable based on E-antigen status and inflammatory activity. Current NITs have poor diagnostic performance for following changes in fibrosis with antiviral therapy. However, NITs may have greater clinical utility for determining prognosis in patients with CHB that have advanced disease, especially for the development of hepatocellular carcinoma and/or liver decompensation. Algorithms combining serum and imaging NITs appear promising for advanced fibrosis and prognostic risk stratification.

Schlagwörter

Stichwörter der Autor:innen

APRIFIB-4chronic hepatitis Belastographyfibrosisnon-invasive tests

Autor:innen und Institutionen

  • Division of Gastroenterology, University Health Network Toronto, Toronto General Hospital, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada.

ORCID-Profile: Chinmay Bera

Zitieren

APA

Bera, C., Hamdan-Perez, N., & Patel, K. (2024). Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients. Journal of Clinical Medicine, 13(4), 1046. https://doi.org/10.3390/jcm13041046

Vancouver

Bera C, Hamdan-Perez N, Patel K. Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients. Journal of Clinical Medicine. 2024;13(4):1046. doi:10.3390/jcm13041046

BibTeX
@article{Bera2024,
  author = {Bera, Chinmay and Hamdan-Perez, Nashla and Patel, Keyur},
  title = {Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {4},
  pages = {1046},
  doi = {10.3390/jcm13041046}
}
Kostenlos starten →